Carbyne Equity Partners has announced its acquisition of Suanfarma's nutraceutical ingredients business, SuanNutra. A private equity firm that has built its name on investments in growing European businesses with strong market positions and commitments to innovation, this latest acquisition marks Carbyne's entry into the nutraceutical sector, building the Carbyne portfolio of R&D-driven businesses.
“SuanNutra is an impressive nutraceutical ingredients platform with meaningful opportunities ahead–whether through securing dedicated supply chains, broadening its portfolio of clinically validated ingredients or deepening its relevance among an already diverse customer base," said Dr. Markus Petersen, Managing Partner at Carbyne. "We have great confidence in the management team and look forward to building the next chapter together."
The investment
Following its acquisition in 2021 by ARCHIMED, Suanfarma has strengthened ties with key partners and suppliers to support the growth of SuanNutra and its EU based subsidiary, Gonmisol. Since 2023, SuanNutra has been positioning itself to adopt a more customer-centered commercial model, increasing its service quality and reinforcing long-term client relationships. The brand has recorded 10 consecutive quarters of revenue and gross profit growth, showcasing the sustained momentum achieved across the business.
SuanNutra CEO Anthony Weston took to LinkedIn to share his personal thoughts on the acquisition and what it meant for the organization: "I am incredibly proud of what we have achieved. Since beginning this chapter in mid 2023, we have not only delivered consistent growth but also transformed SUANNUTRA including Gonmisol by SUANNUTRA and Monteloeder by SUANNUTRA into a stronger, more focused and more ambitious organization, built on the talent and commitment of our people. My thanks to Stephanie Guillén Díaz, Daniel Mínguez Fuentes and Jaime Durán Sanz, whose leadership—together with the wider team—has been central to this transformation. SUANNUTRA has been shaped above all by its people: their professionalism, integrity and clarity of thought have strengthened our capabilities and helped build the culture we value today."
